Hepatocyte‐derived MASP1‐enriched small extracellular vesicles activate HSCs to promote liver fibrosis
Xianzhi Liu, Siwei Tan, Huiling Liu, Jie Jiang, Xing Wang, Leijia Li, Bin Wu – 17 July 2022
Xianzhi Liu, Siwei Tan, Huiling Liu, Jie Jiang, Xing Wang, Leijia Li, Bin Wu – 17 July 2022
Garrett R. Roll, Cristiano Quintini, David J. Reich – 17 July 2022
Alyson Kaplan, Nabeel Wahid, Brett E. Fortune, Elizabeth Verna, Karim Halazun, Benjamin Samstein, Robert S. Brown, Russell Rosenblatt – 17 July 2022 – Although sex and racial disparities for liver transplantation (LT) are known, it is unclear if disparities exist for patients with alcohol‐associated liver disease (ALD). We aimed to compare sex and racial/ethnic differences in mortality, LT listing, and LT rates in patients with and without ALD.
Mallika Mathur, Yu‐Te Yeh, Rakesh K. Arya, Long Jiang, Majid Pornour, Weiping Chen, Yinyan Ma, Bin Gao, Ling He, Zhekang Ying, Bingzhong Xue, Hang Shi, Youngshim Choi, Liqing Yu – 17 July 2022
Kazuya Hirukawa, Yuki Masuda, Yuta Abe, Hiroshi Yagi, Sho Ibuki, Osamu Itano, Masahiro Shinoda, Minoru Kitago, Yasushi Hasegawa, Shutaro Hori, Masayuki Tanaka, Yutaka Nakano, Kentaro Matsubara, Hideaki Obara, Yohei Yamada, Tatsuo Kuroda, Taizo Hibi, Yuko Kitagawa – 17 July 2022 – Biliary complications after hepatectomy in living donors have yet to be eradicated.
Chathur Acharya, Sara McGeorge, Andrew Fagan, James B. Wade, Hannah Lee, Velimir Luketic, Richard K. Sterling, Leroy Thacker, Jasmohan S. Bajaj – 16 July 2022 – Driving is independently affected by cirrhosis and hepatic encephalopathy (HE) and alcohol/substance use, but their concomitant impact is unclear. We aimed to determine the impact of alcohol and other substances on driving‐simulator performance in cirrhosis with and without HE.
Saad Emhmed Ali, Philip Vutien, C. Andrew Bonham, Charles Landis, Paul Kwo, Carlos Esquivel, Mindie H. Nguyen – 16 July 2022 – The demand for orthotopic liver transplantation (OLT) is projected to increase, which indicates a need to expand the liver donor pool. We aimed to investigate the use of hepatitis B virus (HBV)–positive grafts and the outcomes of recipients undergoing OLT with HBV‐positive grafts.
Shih‐Wei Lai – 16 July 2022
Brian Mau, Melanie Hakar, Henry C. Lin, Jessica L. Davis – 15 July 2022
Brian Mau, Melanie Hakar, Henry C. Lin, Jessica L. Davis – 15 July 2022